Preliminary findings from a phase I, open-label, dose-finding study of SNB-101 in patients with advanced solid tumors

被引：0
|
作者：
Sang, Y. B. [1 ]
Kim, Y. [1 ]
Lee, M. A. [2 ]
Rha, S. Y. [3 ]
Jung, M. [3 ]
Lee, C-K. [3 ]
Park, Y. H. [4 ]
Heo, D. [4 ]
Kim, A. [4 ]
Kim, J. [4 ]
Kim, J-H. [1 ]
机构：
[1] CHA Univ, Med Oncol, CHA Bundang Med Ctr, Seongnam, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Med Oncol, Seoul, South Korea
[3] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Med Oncol, Seoul, South Korea
[4] SN BioSci, Med Oncol, Seongnam, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1863
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
677P
引用
收藏
页码：S474 / S474
页数：1
相关论文
共 50 条
  • [31] Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
    Fumoleau, Pierre
    Trigo, Jose Manuel
    Isambert, Nicolas
    Semiond, Dorothee
    Gupta, Sunil
    Campone, Mario
    BMC CANCER, 2013, 13
  • [32] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    E Boven
    C Massard
    J P Armand
    C Tillier
    V Hartog
    N M Brega
    A M Countouriotis
    A Ruiz-Garcia
    J C Soria
    British Journal of Cancer, 2010, 103 : 993 - 1000
  • [33] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Countouriotis, A. M.
    Ruiz-Garcia, A.
    Soria, J. C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (07) : 993 - 1000
  • [34] Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
    Simonelli, M.
    Garralda, E.
    Eskens, F.
    Gil-Martin, M.
    Yen, C-J
    Obermannova, R.
    Chao, Y.
    Lonardi, S.
    Melichar, B.
    Moreno, V
    Yu, M-L
    Bongiovanni, A.
    Calvo, E.
    Rottey, S.
    Machiels, J-P
    Gonzalez-Martin, A.
    Paz-Ares, L.
    Chang, C-L
    Mason, W.
    Lin, C-C
    Reardon, D. A.
    Vieito, M.
    Santoro, A.
    Meng, R.
    Abbadessa, G.
    Menas, F.
    Lee, H.
    Liu, Q.
    Combeau, C.
    Ternes, N.
    Ziti-Ljajic, S.
    Massard, C.
    ESMO OPEN, 2022, 7 (05)
  • [35] A phase 1, open-label, dose escalation study of AMG 337 in Asian patients (pts) with advanced solid tumors
    Yasui, Hirofumi
    Amore, Benny
    Jiang, Yizhou
    Murugappan, Swaminathan
    Doi, Toshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
    Goel, Sanjay
    Swami, Umang
    Kumar, Kirushna
    Dittrich, Christian
    Reyderman, Larisa
    Jain, Minish
    Aisner, Joseph
    Song, James
    Petrylak, Daniel P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (03) : 567 - 578
  • [37] A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
    Sanjay Goel
    Umang Swami
    Kirushna Kumar
    Christian Dittrich
    Larisa Reyderman
    Minish Jain
    Joseph Aisner
    James Song
    Daniel P. Petrylak
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 567 - 578
  • [38] Phase I dose-finding study of trabectedin (T) in combination with cisplatin (C) in patients (pts) with advanced solid tumors.
    Sessa, C.
    Gallerani, E.
    Del Conte, G.
    Christinat, A.
    Perotti, A.
    Lardelli, P.
    Kahatt, C. M.
    Florez, A.
    Fernandez, C.
    Miani, M.
    Gianni, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial
    Gelbenegger, Georg
    Grafeneder, Juergen
    Gager, Gloria M.
    Siller-Matula, Jolanta M.
    Schwameis, Michael
    Jilma, Bernd
    Schoergenhofer, Christian
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [40] Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial
    Georg Gelbenegger
    Juergen Grafeneder
    Gloria M. Gager
    Jolanta M. Siller-Matula
    Michael Schwameis
    Bernd Jilma
    Christian Schoergenhofer
    Thrombosis Journal, 20
12345